Beta-1,3 Oligoglucans Specifically Bind to Immune Receptor CD28 and May Enhance T Cell Activation

Autor: Brian V. Geisbrecht, Susumu Ishiguro, Ariela Vergara-Jaque, Molly Bassette, Jeffrey Comer, Ettayapuram Ramaprasad Azhagiya Singam, Ayaka Nakashima, Kengo Suzuki, Masaaki Tamura, Riley Burghart, Mayme Loyd
Rok vydání: 2021
Předmět:
Models
Molecular

0301 basic medicine
beta-Glucans
T-Lymphocytes
Immune receptor
Lymphocyte Activation
01 natural sciences
lcsh:Chemistry
Jurkat Cells
free energy calculation
beta glucans
Receptors
Immunologic

Receptor
lcsh:QH301-705.5
Spectroscopy
010304 chemical physics
T cell activation
Chemistry
CD28
General Medicine
Computer Science Applications
Cell biology
molecular dynamics simulation
medicine.anatomical_structure
Cytokines
Thermodynamics
Protein Binding
immune stimulation
T cell
T-Cell Receptor Activation
Article
Catalysis
Inorganic Chemistry
03 medical and health sciences
CD28 Antigens
0103 physical sciences
medicine
Humans
oligomers
Physical and Theoretical Chemistry
Binding site
Molecular Biology
CD86
oligoglucans
Organic Chemistry
CD3
030104 developmental biology
lcsh:Biology (General)
lcsh:QD1-999
CD80
Zdroj: International Journal of Molecular Sciences
Volume 22
Issue 6
International Journal of Molecular Sciences, Vol 22, Iss 3124, p 3124 (2021)
ISSN: 1422-0067
DOI: 10.3390/ijms22063124
Popis: Beta glucans are known to have immunomodulatory effects that mediated by a variety of mechanisms. In this article, we describe experiments and simulations suggesting that beta-1,3 glucans may promote activation of T cells by a previously unknown mechanism. First, we find that treatment of a T lymphoblast cell line with beta-1,3 oligoglucan significantly increases mRNA levels of T cell activation-associated cytokines, especially in the presence of the agonistic anti-CD3 antibody. This immunostimulatory activity was observed in the absence of dectin-1, a known receptor for beta-1,3 glucans. To clarify the molecular mechanism underlying this activity, we performed a series of molecular dynamics simulations and free-energy calculations to explore the interaction of beta-1,3 oligoglucans with potential immune receptors. While the simulations reveal little association between beta-1,3 oligoglucan and the immune receptor CD3, we find that beta-1,3 oligoglucans bind to CD28 near the region identified as the binding site for its natural ligands CD80 and CD86. Using a rigorous absolute binding free-energy technique, we calculate a dissociation constant in the low millimolar range for binding of 8-mer beta-1,3 oligoglucan to this site on CD28. The simulations show this binding to be specific, as no such association is computed for alpha-1,4 oligoglucan. This study suggests that beta-1,3 glucans bind to CD28 and may stimulate T cell activation collaboratively with T cell receptor activation, thereby stimulating immune function.
Databáze: OpenAIRE